Genetic Engineering of Hematopoiesis for Targeted IFN-α Delivery Inhibits Breast Cancer Progression-Reference-Cited by-同舟云学术

Genetic Engineering of Hematopoiesis for Targeted IFN-α Delivery Inhibits Breast Cancer Progression

Published:2014-01 Issue:217 Volume:6 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Escobar Giulia¹²,Moi Davide²,Ranghetti Anna²,Ozkal-Baydin Pinar²,Squadrito Mario Leonardo¹²,Kajaste-Rudnitski Anna²,Bondanza Attilio¹³,Gentner Bernhard¹²,De Palma Michele²,Mazzieri Roberta²,Naldini Luigi¹²

Affiliation:

1. Vita-Salute San Raffaele University, 20132 Milan, Italy.

2. Angiogenesis and Tumor Targeting Research Unit and San Raffaele Telethon Institute for Gene Therapy, San Raffaele Scientific Institute, 20132 Milan, Italy.

3. Leukemia Immunotherapy Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.

Abstract

Inhibition of primary and metastatic breast cancer by targeted delivery of interferon-α by tumor-infiltrating monocytes.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference47 articles.

1. Natural Innate and Adaptive Immunity to Cancer

2. Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer

3. Cancer Immunotherapy Comes of Age

4. The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells

5. A critical function for type I interferons in cancer immunoediting

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering interferons for cancer immunotherapy;Biomedicine & Pharmacotherapy;2024-10

2. Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach;Nature Reviews Clinical Oncology;2024-09-04

3. Microglia-specific IL-10 gene delivery inhibits neuroinflammation and neurodegeneration in a mouse model of Parkinson’s disease;Science Translational Medicine;2024-08-21

4. Challenges and successes in cellular therapies and CAR-T: insights from the 50th EBMT annual meeting;Bone Marrow Transplantation;2024-07-23

5. Targeting cytokine and chemokine signaling pathways for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-22